Patients with a diagnosis of primary HLH
Patient . | Age/sex . | NK LU . | % . | % perforin . | Nucleotide change . | Amino acid change . | ||
---|---|---|---|---|---|---|---|---|
NK . | CD8 . | CD56 . | ||||||
P9 | 3 mo/F | 0.00↓ | 2↓ | 0↓ | 0 | 0↓ | 50delT* | Leu17X |
P11 | 8 mo/M | 0.00↓ | 9 | 0↓ | 0 | 0↓ | 50delT* | Leu17X |
P10 | 3 y/F | 0.12↓ | 6 | 61↓ | 0↓ | 0↓ | 133G>A† | Gly45Arg |
160C>T† | Arg54Ser | |||||||
P1 | 10 y/F | 0.01↓ | 18 | 1↓ | 0↓ | 0↓ | 116C>A† | Pro39His |
445G>A† | Gly149Ser | |||||||
P6 | 2 mo/F | 0.00↓ | 39 | 96 | 0 | 31 | No mutation | |
P7 | 4 mo/F | 0.00↓ | 1↓ | 83 | 1 | 4 | No mutation | |
P2 | 7 mo/F | 0.00↓ | 21 | 91 | 1 | 25 | No mutation | |
Normal values | 0-1 y | 3 -17 | 91-97 | 0-3 | 4-30 | |||
>3.2 | ||||||||
1-15 y | 4-22 | 81-91 | 2-11 | 12-34 |
Patient . | Age/sex . | NK LU . | % . | % perforin . | Nucleotide change . | Amino acid change . | ||
---|---|---|---|---|---|---|---|---|
NK . | CD8 . | CD56 . | ||||||
P9 | 3 mo/F | 0.00↓ | 2↓ | 0↓ | 0 | 0↓ | 50delT* | Leu17X |
P11 | 8 mo/M | 0.00↓ | 9 | 0↓ | 0 | 0↓ | 50delT* | Leu17X |
P10 | 3 y/F | 0.12↓ | 6 | 61↓ | 0↓ | 0↓ | 133G>A† | Gly45Arg |
160C>T† | Arg54Ser | |||||||
P1 | 10 y/F | 0.01↓ | 18 | 1↓ | 0↓ | 0↓ | 116C>A† | Pro39His |
445G>A† | Gly149Ser | |||||||
P6 | 2 mo/F | 0.00↓ | 39 | 96 | 0 | 31 | No mutation | |
P7 | 4 mo/F | 0.00↓ | 1↓ | 83 | 1 | 4 | No mutation | |
P2 | 7 mo/F | 0.00↓ | 21 | 91 | 1 | 25 | No mutation | |
Normal values | 0-1 y | 3 -17 | 91-97 | 0-3 | 4-30 | |||
>3.2 | ||||||||
1-15 y | 4-22 | 81-91 | 2-11 | 12-34 |
All patients demonstrated absent NK function. Patients P1, P9, and P11 showed lack of intracellular perforin in all cytotoxic cell types (complete deficiency). Patient P10 showed lack of intracellular perforin in CD8+ and CD56+ T cells and a very low positivity of perforin staining in the NK cells (partial deficiency). The other three patients with presumed primary HLH had normal percentages of perforin positive cytotoxic cells for age.
Homozygous mutation.
Heterozygous mutation.